Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Widget

Add BioCurex widget to your own site or blog

Email Updates

Search

AGORACOM News Flash

AGORACOM CONFERENCE UPDATE

  • 12 More Companies Added To Schedule For Dec 3 & 4. (See Schedule)
  • Keynote Speakers Include Peter Grandich, Eric Coffin (See Speakers)
  • Workshop Presentations Added To Thursday Schedule
  • Investors from over 45 Countries Have Visited
  • Conference Begins 2 Weeks From Today!

Looking forward to seeing all of you there gang.  Registration is free for investors.  AGORACOM Members register with just one click.  Non-members takes less than 60 seconds.  Register here (see form on right hand side)

 

Message: The real story on the loan(s)

Al_bundy_400_profile
Rank: [?]
Vice President
Points: [?]
1123
Rating: [?]
Votes: 15 Score: 3.5
  • Currently 3.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

The real story on the loan(s)

posted on Oct 22, 09 07:02PM

On June 29, 2007, Biocurex sold convertible notes, plus warrants, to two private investors for $3,000,000.

Keep in mind the following 1. All defaults under the Notes are waived provided that:

o Biocurex receives at least $350,000 from the sale of promissory notes prior to October 1, 2009; and

o Biocurex receives gross proceeds of at least $3,000,000 from the public sale of its securities (the "Public Offering");

o Biocurex uses the greater of $600,000 or 20% of the proceeds from the public sale of its securities to repay the notes.

Advancements require Money. This is a Fact of Life in the business world. Dr. Moro did not "Toss the Money away" He used it in the following areas. He will use our new money to drive Recaf all the way to the finish line. Mark My Words!

Since June of 2007 the following advancements have been made:

http://www.biocurex.com/curexhtml/news/news94.htm

http://www.biocurex.com/curexhtml/news/news95.htm

http://www.biocurex.com/curexhtml/news/news97.htm

http://www.biocurex.com/curexhtml/news/news100.htm

http://www.biocurex.com/curexhtml/news/news101.htm

http://www.biocurex.com/curexhtml/news/news102.htm

http://www.biocurex.com/curexhtml/news/news104.htm

http://www.biocurex.com/curexhtml/news/news105.htm

http://www.biocurex.com/curexhtml/news/news106.htm

http://www.biocurex.com/curexhtml/news/news108.htm

http://www.biocurex.com/curexhtml/news/news109.htm

http://www.biocurex.com/curexhtml/news/news111.htm

http://www.biocurex.com/curexhtml/news/news112.htm

http://www.biocurex.com/curexhtml/news/news113.htm

http://www.biocurex.com/curexhtml/news/news114.htm

http://www.reuters.com/article/pressRelease/idUS153540+24-Jul-2008+MW20080724

New Message

Please login to post a reply

AGORACOM Quick Tips

Testimonials. Members Sure Love AGORACOM! ... Get On The List!

Executive Address

Bocx-ricardo-ea
Dr. Ricardo Moro
President & CEO
November 27, 2008

Dr. Moro discusses Biocurex's latest developments

View Broadcast

Stock Quote